Testing the Addition of Iberdomide to Therapy in People With Neuroblastoma That Has Come Back, Not Responded to Treatment, or Gotten Worse

Clinical trial NCT07437963 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07437963
Sponsor: National Cancer Institute (NCI)
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Recurrent Ganglioneuroblastoma Recurrent Neuroblastoma Refractory Ganglioneuroblastoma Refractory Neuroblastoma

Start date: 2026-10-28
Primary completion: 2029-09-30
Enrollment: 76

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.